These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22736575)

  • 21. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders.
    Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y
    J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTSD and stress sensitisation: a tale of brain and body Part 1: human studies.
    Stam R
    Neurosci Biobehav Rev; 2007; 31(4):530-57. PubMed ID: 17270271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
    Rodas JD; George TP; Hassan AN
    J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
    [No Abstract]   [Full Text] [Related]  

  • 24. Cannabinoid interventions for PTSD: Where to next?
    Ney LJ; Matthews A; Bruno R; Felmingham KL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():124-140. PubMed ID: 30946942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder.
    LaFrance EM; Glodosky NC; Bonn-Miller M; Cuttler C
    J Affect Disord; 2020 Sep; 274():298-304. PubMed ID: 32469819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers.
    de Bitencourt RM; Pamplona FA; Takahashi RN
    Neuropharmacology; 2013 Jan; 64():389-95. PubMed ID: 22687521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.
    Greer GR; Grob CS; Halberstadt AL
    J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach.
    de Quervain DJ; Margraf J
    Eur J Pharmacol; 2008 Apr; 583(2-3):365-71. PubMed ID: 18275950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Post-traumatic stress, post-traumatic depression and major depressive episode: literature].
    Ducrocq F; Vaiva G; Cottencin O; Molenda S; Bailly D
    Encephale; 2001; 27(2):159-68. PubMed ID: 11407268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.
    Shannon S; Opila-Lehman J
    Perm J; 2016; 20(4):16-005. PubMed ID: 27768570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options.
    Locci A; Pinna G
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():243-259. PubMed ID: 30586627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panicogens in patients with Post-Traumatic Stress Disorder (PTSD).
    Muhtz C; Wiedemann K; Kellner M
    Curr Pharm Des; 2012; 18(35):5608-18. PubMed ID: 22632476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
    J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis for inflammatory bowel disease.
    Naftali T; Mechulam R; Lev LB; Konikoff FM
    Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Magneto-encephalographic (MEG) brain recordings during traumatic memory recall in women with post-traumatic stress disorder: A pilot study].
    Cottraux J; Lecaignard F; Yao SN; De Mey-Guillard C; Haour F; Delpuech C; Servan-Schreiber D
    Encephale; 2015 Jun; 41(3):202-8. PubMed ID: 24793794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.
    Raut SB; Marathe PA; van Eijk L; Eri R; Ravindran M; Benedek DM; Ursano RJ; Canales JJ; Johnson LR
    Pharmacol Ther; 2022 Nov; 239():108195. PubMed ID: 35489438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches.
    Kondev V; Winters N; Patel S
    Int Rev Neurobiol; 2021; 157():143-193. PubMed ID: 33648669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel combination strategy to optimize treatment for PTSD.
    Shad MU; Suris AM; North CS
    Hum Psychopharmacol; 2011 Jan; 26(1):4-11. PubMed ID: 21308782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment.
    Buckner JD; Jeffries ER; Crosby RD; Zvolensky MJ; Cavanaugh CE; Wonderlich SA
    Am J Drug Alcohol Abuse; 2018; 44(5):532-542. PubMed ID: 29442522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.